percutaneous tracheostomy in patients with severe liver disease and a high incidence of refractory coagulopathy a prospective trial经皮气管造口术患者的严重肝脏疾病和耐火凝血病高发的一个前瞻性的试验.pdf

Available online /content/11/5/R110 Vol 11 No 5 Open Access Research Percutaneous tracheostomy in patients with severe liver disease and a high incidence of refractory coagulopathy: a prospective trial Georg Auzinger, Gerry P OCallaghan, William Bernal, Elizabeth Sizer and Julia A Wendon Institute of Liver Studies, Liver Intensive Care Unit, Kings College Hospital, Denmark Hill, London SE5 9RS, UK Corresponding author: Georg Auzinger, georg.auzinger@kingsch.nhs.uk Received: 12 Apr 2007 Revisions requested: 31 May 2007 Revisions received: 10 Aug 2007 Accepted: 8 Oct 2007 Published: 8 Oct 2007 Critical Care 2007, 11:R110 (doi:10.1186/cc6143) This article is online at: /content/11/5/R110 © 2007 Auzinger et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Introduction The purpose of this study was to assess the safety the number of adverse incidents between groups. Only one of percutaneous dilational tracheostomy (PDT) performed by patient in the coagulopathy group had a severe bleeding experienced operators in critically ill patients with liver disease complication, but this did not require open surgical intervention. and coagulopathy. The rate of clinically relevant early complications in all patients was not higher than expected (n = 7, 12%). Resource uti